TY - CHAP
T1 - Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD
AU - Yde Ohki, Cristine Marie
AU - McNeill, Rhiannon V.
AU - Nieberler, Matthias
AU - Radtke, Franziska
AU - Kittel-Schneider, Sarah
AU - Grünblatt, Edna
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.
PY - 2022
Y1 - 2022
N2 - Although research using animal models, peripheral and clinical biomarkers, multimodal neuroimaging techniques and (epi)genetic information has advanced our understanding of Attention-Deficit Hyperactivity Disorder (ADHD), the aetiopathology of this neurodevelopmental disorder has still not been elucidated. Moreover, as the primary affected tissue is the brain, access to samples is problematic. Alternative models are therefore required, facilitating cellular and molecular analysis. Recent developments in stem cell research have introduced the possibility to reprogram somatic cells from patients, in this case ADHD, and healthy controls back into their pluripotent state, meaning that they can then be differentiated into any cell or tissue type. The potential to translate patients’ somatic cells into stem cells, and thereafter to use 2- and 3-dimensional (2D and 3D) neuronal cells to model neurodevelopmental disorders and/or test novel drug therapeutics, is discussed in this chapter.
AB - Although research using animal models, peripheral and clinical biomarkers, multimodal neuroimaging techniques and (epi)genetic information has advanced our understanding of Attention-Deficit Hyperactivity Disorder (ADHD), the aetiopathology of this neurodevelopmental disorder has still not been elucidated. Moreover, as the primary affected tissue is the brain, access to samples is problematic. Alternative models are therefore required, facilitating cellular and molecular analysis. Recent developments in stem cell research have introduced the possibility to reprogram somatic cells from patients, in this case ADHD, and healthy controls back into their pluripotent state, meaning that they can then be differentiated into any cell or tissue type. The potential to translate patients’ somatic cells into stem cells, and thereafter to use 2- and 3-dimensional (2D and 3D) neuronal cells to model neurodevelopmental disorders and/or test novel drug therapeutics, is discussed in this chapter.
KW - Attention-deficit disorder (ADD)
KW - Attention-deficit hyperactivity disorder (ADHD)
KW - Cell models
KW - Induced pluripotent stem cells (iPSC)
KW - Neuronal cells
KW - Personalized modelling
UR - https://www.scopus.com/pages/publications/85135594385
U2 - 10.1007/7854_2022_346
DO - 10.1007/7854_2022_346
M3 - Chapter
C2 - 35543866
AN - SCOPUS:85135594385
T3 - Current Topics in Behavioral Neurosciences
SP - 483
EP - 501
BT - Current Topics in Behavioral Neurosciences
PB - Springer Science and Business Media Deutschland GmbH
ER -